Literature DB >> 6091460

Epidemiology of gestational trophoblastic disease.

D A Grimes.   

Abstract

The epidemiology of gestational trophoblastic disease is not well understood. Methodologic problems with published reports limit the interpretation of incidence data, although the frequency of hydatidiform mole appears to be about one per 1000 pregnancies. No consistent temporal trends in rates of either hydatidiform mole or choriocarcinoma are evident. Hydatidiform mole appears to be caused by abnormal gametogenesis and fertilization. Age, ethnicity, and a history of hydatidiform mole appear to be important risk factors for hydatidiform mole. Age, ethnicity, a history of hydatidiform mole or fetal wastage, and ABO blood group interactions appear to be important risk factors for choriocarcinoma. Future studies should focus on the mechanisms by which these risk factors influence gametogenesis, fertilization, and malignant transformation of trophoblastic tissue.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091460     DOI: 10.1016/s0002-9378(84)90370-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  Efficient approach to unique single-nucleotide polymorphism discovery.

Authors:  P Taillon-Miller; E E Piernot; P Y Kwok
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

2.  Alkaline phosphatase histochemistry and biochemistry in the diagnosis of complete hydatidiform mole.

Authors:  M Salehnia; T R Farzad; M Tachikhani; S S Torghaban; T Al-Traihi
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Epidemiological study of complete and partial hydatidiform mole in Abu Dhabi: influence age and ethnic group.

Authors:  I H Graham; A M Fajardo; R L Richards
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

4.  A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation.

Authors:  R Slim; R Bagga; W Chebaro; R Srinivasan; N Agarwal
Journal:  Clin Genet       Date:  2009-07-24       Impact factor: 4.438

5.  When listening for hoofbeats, sometimes there are zebras-an interesting case of a teenager with edema and high blood pressure: Answers.

Authors:  Katayun Taasoobshirazi; Donald L Batisky
Journal:  Pediatr Nephrol       Date:  2014-01-14       Impact factor: 3.714

6.  Prevalence of gestational trophoblastic disease in ectopic pregnancy.

Authors:  Ilir Tasha; Enriketa Kroi; Anila Karameta; Rozeta Shahinaj; Nikita Manoku
Journal:  J Prenat Med       Date:  2010-04

7.  Report of four new patients with protein-truncating mutations in C6orf221/KHDC3L and colocalization with NLRP7.

Authors:  Ramesh Reddy; Elie Akoury; Ngoc Minh Phuong Nguyen; Omar A Abdul-Rahman; Christine Dery; Neerja Gupta; William P Daley; Asangla Ao; Hanene Landolsi; Rosemary Ann Fisher; Isabelle Touitou; Rima Slim
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

8.  Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China.

Authors:  M Su; S M Lu; D P Tian; H Zhao; X Y Li; D R Li; Z C Zheng
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

9.  The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions.

Authors:  Ramesh Reddy; Ngoc M P Nguyen; Guillaume Sarrabay; Maryam Rezaei; Mayra C G Rivas; Aysenur Kavasoglu; Hakan Berkil; Alaa Elshafey; Ebtesam Abdalla; Kristin P Nunez; Hélène Dreyfus; Merviel Philippe; Zahra Hadipour; Asude Durmaz; Erin E Eaton; Brittany Schubert; Volkan Ulker; Fatemeh Hadipour; Fatemeh Ahmadpour; Isabelle Touitou; Majid Fardaei; Rima Slim
Journal:  Eur J Hum Genet       Date:  2016-03-09       Impact factor: 4.246

10.  Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast.

Authors:  G L Mutter; C L Stewart; M L Chaponot; R J Pomponio
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.